Literature DB >> 16163479

[Small suggestive lesions of the prostate. Histological and immunohistochemical analyses -- report of the uropathology consultation service].

B Helpap1.   

Abstract

Punch biopsies have been taken from the prostate with increasing frequency in recent years, with a resulting increase in the number of diagnoses made. To check the diagnosis of "small two- or three-gland carcinoma" we prepared new H and E sections and, when the atypical glands were no longer available, also performed immunohistochemical analyses in 1,041 cases referred to our uropathology consultation service, comparing the diagnoses supplied by the referring doctors with the final diagnoses. In 61.6 of these cases histology confirmed the diagnosis of adenocarcinoma of the prostate; the diagnosis recorded when the basal cell marker was absent and the tumour marker P504S was strongly expressed was atypical microglandular proliferation or suspected carcinoma. Previous diagnoses of prostatic carcinoma were confirmed in 99% of cases. In this way we also confirmed a further 27.9% of cases of prostate carcinoma in the grey area of diagnoses endorsed "suggestive" or "suspected". The patients concerned were thus spared multiple screening biopsies and were assigned for definitive treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16163479     DOI: 10.1007/s00292-005-0787-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  26 in total

Review 1.  Atypical acinar proliferations of the prostate.

Authors:  B Helpap; J Köllermann
Journal:  Pathol Res Pract       Date:  1999       Impact factor: 3.250

2.  Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.

Authors:  Rajal B Shah; Ming Zhou; Michele LeBlanc; Matthew Snyder; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

3.  P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies.

Authors:  R Beach; A M Gown; M N De Peralta-Venturina; A L Folpe; H Yaziji; P G Salles; D J Grignon; G R Fanger; M B Amin
Journal:  Am J Surg Pathol       Date:  2002-12       Impact factor: 6.394

4.  Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.

Authors:  Z Jiang; C L Wu; B A Woda; K A Iczkowski; P G Chu; M S Tretiakova; R H Young; L M Weiss; R D Blute; C B Brendler; T Krausz; J C Xu; K L Rock; M B Amin; X J Yang
Journal:  Histopathology       Date:  2004-09       Impact factor: 5.087

5.  Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases.

Authors:  Zhong Jiang; Gary R Fanger; Bruce A Woda; Barbara F Banner; Paul Algate; Karen Dresser; Jiangchun Xu; Peiguo G Chu
Journal:  Hum Pathol       Date:  2003-08       Impact factor: 3.466

6.  Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer.

Authors:  K A Iczkowski; T J Bassler; V S Schwob; I C Bassler; B S Kunnel; R E Orozco; D G Bostwick
Journal:  Urology       Date:  1998-05       Impact factor: 2.649

7.  P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens.

Authors:  Zhong Jiang; Kenneth A Iczkowski; Bruce A Woda; Maria Tretiakova; Ximing J Yang
Journal:  Am J Clin Pathol       Date:  2004-01       Impact factor: 2.493

8.  The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases.

Authors:  K J Wojno; J I Epstein
Journal:  Am J Surg Pathol       Date:  1995-03       Impact factor: 6.394

9.  P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy.

Authors:  Zhong Jiang; Chin-Lee Wu; Bruce A Woda; Karen Dresser; Jiangchun Xu; Gary R Fanger; Ximing J Yang
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

10.  Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy.

Authors:  J I Epstein
Journal:  Hum Pathol       Date:  1995-02       Impact factor: 3.466

View more
  2 in total

1.  The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.

Authors:  Burkhard Helpap; Lars Egevad
Journal:  Virchows Arch       Date:  2006-11-08       Impact factor: 4.064

2.  [Importance of second opinions on histology of prostate biopsy specimens].

Authors:  B Helpap; U Oehler
Journal:  Pathologe       Date:  2012-03       Impact factor: 1.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.